News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ
Jan 21, 2025, 05:12

Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:

“Intratumoral, pembrolizumab and mRNA-2752 for high-risk DCIS : Phase 1 nonrandomized trial

80% response rate
no major systemic toxicities
complete tumor resolution in some possible surgery reduction
Ongoing studies needed.”

Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In SituA Phase 1 Nonrandomized Clinical Trial

Authors: Kirithiga Ramalingam, Rachel Woody, Alexa Glencer

Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ

Alexa Glencer cancer Kirithiga Ramalingam Kristina Jankovic OncoDaily Oncology Rachel Woody
Special Coverage
Blog
Apr 2, 2025, 11:34
"Healthcare system changes will not affect Medicaid or Medicare" - says Robert F. Kennedy Jr.
Blog
Apr 2, 2025, 11:26
Alec C. Kimmelman has been appointed as the next Chief Executive Officer and Dean of NYU Langone Health
Blog
Apr 2, 2025, 11:14
FDA welcomes Martin A. Makary as the 27th Commissioner of the U.S. Food and Drug Administration
Science
Apr 2, 2025, 11:04
Shilpa Gupta: Safety and tolerability of maintenance avelumab in elderly patients subgroup from Javelin Bladder 100 trial
Science
Apr 2, 2025, 10:53
Diego A. Díaz García: Cross-priming is key in cancer immunotherapy
Science
Apr 2, 2025, 10:29
Bishal Gyawali: Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers
Blog
Apr 2, 2025, 10:15
IMF Regional Community Workshop to learn all about MM - International Myeloma Foundation
Blog
Apr 2, 2025, 10:10
Ready to coordinate Advisory Board in Basilicata to improve oncology research - Sbarro Health Research Organization
Blog
Apr 2, 2025, 10:07
Teresa Amaral: Discussing neoadjuvant therapy in skin cancer at the 27th International Dermatology Meeting
Blog
Apr 2, 2025, 10:05
Wafaa M Rashed: Personalized HIV Treatment in Africa
Career
Apr 2, 2025, 10:01
Karen Knudsen: I’ve taken the helm of Parker Institute for Cancer Immunotherapy (PICI) as CEO
Blog
Apr 2, 2025, 09:58
John F. Kurland presented about immuno-oncology therapies at the IO360 Summit